Patent Assignment
Reel/Frame 012973/0152
Corrective Assignment to Correct the Patent Number from 6-154,470 to 6,165,470. Document Previously Recorded at Reel 012653 Frame 0458.
Recorded: 2002-06-05
Pages: 7
Assignor
RHONE-POULENC RORER S.A.
Executed: 2002-03-01
Assignee
CENTEON L.L.C.
1020 FIRST AVENUE, KING OF PRUSSIA, PENNSYLVANIA, 19406
Covered Property
(1)
Albumin Derivatives with Therapeutic Functions
Patent:
6,165,470 →
Application:
09/004,319 →
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Contract
Mar 1, 2002
From: RHONE-POULENC RORER S.A.
To: CENTEON L.L.C.
Reel/Frame 012653/0458 →
Change of Name
Mar 11, 2002
From: CENTEON L.L.C.
To: AVENTIS BEHRING L.L.C.
Reel/Frame 012698/0406 →
Change of Name
Aug 25, 2011
From: DELTA BIOTECHNOLOGY LIMITED
To: NOVOZYMES BIOPHARMA UK LIMITED
Reel/Frame 026808/0549 →
Assignment of Assignor's Interest
Aug 26, 2011
From: NOVOZYMES BIOPHARMA UK LIMITED
To: NOVOZYMES BIOPHARMA DK A/S
Reel/Frame 026813/0938 →